Carcinoembryonic antigen (CEA) is a common tumor marker, and a meta-analysis of non-small cell lung cancer (NSCLC) [7] showed that CEA is significantly associated with epidermal growth factor receptor (EGFR) mutations and lung cancer staging. This evidence concerns the gene CEACAM5 and non-small cell lung carcinoma.